Sterne Agee analyst David Bain raised estimates and his price target on Buy-rated Las Vegas Sands (NYSE: LVS) from $88 to $92 following Q1 results saying there were "just what the doctor ordered."

Bain commented, "Today’s earnings delivered what investors “needed” to regain a more bullish outlook on LVS (and Macau names, in general): solid 1Q14 earnings, strong shareholder capital returns, and management comments that Macau VIP liquidity/credit or other Island concerns are over-amplified and not currently being felt. We believe investor focus returns to cash flow growth dynamics, new expansion opportunities, and additional shareholder capital return potential as we enter the May 1 holiday in Macau."

CY14/CY15 EPS goes to $3.86/$4.28 from $3.67/$4.14 and CY14/CY15 EBITDA goes to $5.7b/$6.2b from $5.5b/$6.1b. Changes reflect higher Macau margin assumptions, slightly higher Macau revenue, and a reduction in shares outstanding.

For an analyst ratings summary and ratings history on Las Vegas Sands click here. For more ratings news on Las Vegas Sands click here.

Shares of Las Vegas Sands closed at $79.48 yesterday.